What is a stock summary page? Click here for an overview.
Business Description
Dr. Martens PLC
ISIN : GB00BL6NGV24
Share Class Description:
DOCMF: Ordinary SharesCompare
Compare
Traded in other countries / regions
DOCS.UKDOCMF.USA3U2.GermanyDOCS.Mexico IPO Date
2021-02-04Description
Dr. Martens PLC is engaged in the business of footwear. Its product segments include Originals, Fusion, Kids and Casual, and a complementary range of Accessories. Geographically, it derives a majority of revenue from EMEA and also has a presence in the Americas and APAC.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.21 | |||||
| Equity-to-Asset | 0.36 | |||||
| Debt-to-Equity | 1.34 | |||||
| Debt-to-EBITDA | 3.19 | |||||
| Interest Coverage | 2.36 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 4.8 | |||||
| Beneish M-Score | -3.27 | |||||
| WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 4.8 | |||||
| 3-Year EBITDA Growth Rate | 11.6 | |||||
| 3-Year EPS without NRI Growth Rate | -15.3 | |||||
| 3-Year Book Growth Rate | 36.7 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 58.8 | |||||
| 9-Day RSI | 53.99 | |||||
| 14-Day RSI | 47 | |||||
| 3-1 Month Momentum % | -23.02 | |||||
| 6-1 Month Momentum % | -2.64 | |||||
| 12-1 Month Momentum % | -24.41 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.26 | |||||
| Quick Ratio | 0.99 | |||||
| Cash Ratio | 0.49 | |||||
| Days Inventory | 356.59 | |||||
| Days Sales Outstanding | 40.11 | |||||
| Days Payable | 127.1 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 3.47 | |||||
| Dividend Payout Ratio | 0.38 | |||||
| Forward Dividend Yield % | 3.47 | |||||
| 5-Year Yield-on-Cost % | 3.47 | |||||
| 3-Year Average Share Buyback Ratio | 1.3 | |||||
| Shareholder Yield % | 15.01 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 65.52 | |||||
| Operating Margin % | 8.81 | |||||
| Net Margin % | 3.65 | |||||
| FCF Margin % | 24.97 | |||||
| ROE % | 8.27 | |||||
| ROA % | 3.03 | |||||
| ROIC % | 6.98 | |||||
| 3-Year ROIIC % | 0.16 | |||||
| ROC (Joel Greenblatt) % | 14.41 | |||||
| ROCE % | 8.7 | |||||
| Years of Profitability over Past 10-Year | 6 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 19.26 | |||||
| Forward PE Ratio | 10.5 | |||||
| PE Ratio without NRI | 8.06 | |||||
| Price-to-Owner-Earnings | 3.93 | |||||
| PEG Ratio | 0.41 | |||||
| PS Ratio | 0.63 | |||||
| PB Ratio | 1.51 | |||||
| Price-to-Tangible-Book | 8.67 | |||||
| Price-to-Free-Cash-Flow | 2.47 | |||||
| Price-to-Operating-Cash-Flow | 2.24 | |||||
| EV-to-EBIT | 13.18 | |||||
| EV-to-Forward-EBIT | 8.94 | |||||
| EV-to-EBITDA | 6.31 | |||||
| EV-to-Forward-EBITDA | 4.91 | |||||
| EV-to-Revenue | 1.09 | |||||
| EV-to-Forward-Revenue | 0.99 | |||||
| EV-to-FCF | 4.24 | |||||
| Price-to-GF-Value | 0.28 | |||||
| Price-to-Peter-Lynch-Fair-Value | 0.38 | |||||
| Price-to-Graham-Number | 1.69 | |||||
| Earnings Yield (Greenblatt) % | 7.59 | |||||
| FCF Yield % | 39.15 | |||||
| Forward Rate of Return (Yacktman) % | 38.58 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:DOCMF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Dr. Martens PLC Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 1,040.928 | ||
| EPS (TTM) ($) | 0.036 | ||
| Beta | 0.25 | ||
| 3-Year Sharpe Ratio | -0.97 | ||
| 3-Year Sortino Ratio | -1.24 | ||
| Volatility % | 42.58 | ||
| 14-Day RSI | 47 | ||
| 14-Day ATR ($) | 0.010465 | ||
| 20-Day SMA ($) | 0.675853 | ||
| 12-1 Month Momentum % | -24.41 | ||
| 52-Week Range ($) | 0.618 - 1.13 | ||
| Shares Outstanding (Mil) | 964 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Dr. Martens PLC Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Dr. Martens PLC Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Dr. Martens PLC Frequently Asked Questions
What is Dr. Martens PLC(DOCMF)'s stock price today?
The current price of DOCMF is $0.69. The 52 week high of DOCMF is $1.13 and 52 week low is $0.62.
When is next earnings date of Dr. Martens PLC(DOCMF)?
The next earnings date of Dr. Martens PLC(DOCMF) is 2025-06-05.
Does Dr. Martens PLC(DOCMF) pay dividends? If so, how much?
The Dividend Yield %  of Dr. Martens PLC(DOCMF) is 3.47% (As of Today), Highest Dividend Payout Ratio of Dr. Martens PLC(DOCMF) was 0.83. The lowest was 0.07. And the median was 0.45. The  Forward Dividend Yield % of Dr. Martens PLC(DOCMF) is 3.47%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers